Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...
A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...
While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...
GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...
The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...
Everyday Health on MSN
GLP-1 Drugs Like Ozempic May Boost Colon Cancer Survival
People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...
MedPage Today on MSN
GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients
In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback